SAGE HIV studies
SAGE WOPS study - Wave 2 (2013)
Wave 2 follow-up was started in the first quarter of 2013 in Uganda and South Africa. Wave 1 respondents from Group 2 will “age” into Group 1 for Wave 2. Replacements for losses to follow-up will be added, along with new respondents for Group 2. For respondents who have passed, WHO's 2012 VAQ will be used to determine causes of death.
The SAGE HIV sub-studies are supported by the Division of Behavioral and Social Research (BSR) at the National Institute on Aging (NIA), US National Institutes of Health (NIH). SAGE-WOPS was supported by grant number GHA-G-OO-09-00003 through NIA/NIH. WHO provided salary support for members of the WHO SAGE team.
Further follow-up waves are planned, pending funding.